Benedikt Niedermaier, Raffaella Griffo, Florian Eichhorn, Laura V Klotz, Heidrun Grosch, Thomas Muley, Hauke Winter, Martin E Eichhorn
{"title":"Robot-Assisted Versus Open Surgery for the Resection of Large Thymomas: A Retrospective Cohort Study.","authors":"Benedikt Niedermaier, Raffaella Griffo, Florian Eichhorn, Laura V Klotz, Heidrun Grosch, Thomas Muley, Hauke Winter, Martin E Eichhorn","doi":"10.1002/jso.28113","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Robot-assisted thoracic surgery (RATS) is increasingly becoming the preferred surgical method for the resection of thymomas. We initiated the current study to evaluate perioperative outcomes and early recurrence associated with the surgical approach.</p><p><strong>Methods: </strong>In this retrospective cohort study, 35 patients were included in the RATS group and compared with 29 patients who underwent open surgery between 2010 and 2022 for histologically confirmed large thymoma > 50 mm in TNM Stages I, II, and IIIa.</p><p><strong>Results: </strong>Histologic subtypes and pathologic stages were similar in both groups. The median duration of chest drainage and median length of stay was significantly shorter in the RATS group (1 vs. 4 days, p < 0.0001, and 4 vs. 10 days, p < 0.0001, respectively). Postoperative complications occurred more frequently in the open surgery group (cumulative incidence of 8.6% vs. 37.9%, p = 0.0048). The median follow-up time was 28 months in the RATS group and 69 months in the open surgery group. Five-year recurrence-free survival was 96.9% without significant differences between the two groups.</p><p><strong>Conclusion: </strong>There is no evidence of increased early recurrence associated with robotic surgery. The length of hospital stay, the duration of thoracic drainage, and the significantly lower complications favor the robot-assisted approach.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.28113","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Robot-assisted thoracic surgery (RATS) is increasingly becoming the preferred surgical method for the resection of thymomas. We initiated the current study to evaluate perioperative outcomes and early recurrence associated with the surgical approach.
Methods: In this retrospective cohort study, 35 patients were included in the RATS group and compared with 29 patients who underwent open surgery between 2010 and 2022 for histologically confirmed large thymoma > 50 mm in TNM Stages I, II, and IIIa.
Results: Histologic subtypes and pathologic stages were similar in both groups. The median duration of chest drainage and median length of stay was significantly shorter in the RATS group (1 vs. 4 days, p < 0.0001, and 4 vs. 10 days, p < 0.0001, respectively). Postoperative complications occurred more frequently in the open surgery group (cumulative incidence of 8.6% vs. 37.9%, p = 0.0048). The median follow-up time was 28 months in the RATS group and 69 months in the open surgery group. Five-year recurrence-free survival was 96.9% without significant differences between the two groups.
Conclusion: There is no evidence of increased early recurrence associated with robotic surgery. The length of hospital stay, the duration of thoracic drainage, and the significantly lower complications favor the robot-assisted approach.
期刊介绍:
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.